Tag: automated analyzers market analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Automated Analyzers Market Growth Potential: How Will Market Size Shift Through 2030?

The automated analyzers market has shown significant growth in recent years. This market is set to expand from $5.39 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, the growth was influenced by factors including manual and semi-automated testing methods, limitations in laboratory workforce efficiency, an increase in clinical testing volumes, the expansion of diagnostic laboratories, and a reliance on conventional analyzers.

The automated analyzers market is projected to experience substantial expansion over the coming years. This market is set to reach a valuation of $7.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Key factors contributing to this growth during the projection period include advancements in fully automated analyzer technology, the incorporation of AI and big data analytics, an increasing need for rapid diagnostic tools, the broadening scope of genomics and proteomics research, and the uptake of point-of-care testing solutions. Significant trends anticipated in the forecast timeframe encompass the wider acceptance of automated laboratory systems, a growing requirement for high-throughput sample processing, the integration of multi-functional analyzers within laboratory settings, the expansion of clinical diagnostics and research applications, and improvements in the accuracy and standardization of analytical testing.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=19322&type=smp&name=Automated%20Analyzers%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Automated Analyzers Market Growth Backed By Core Demand Fundamentals

The increasing occurrence of chronic diseases is anticipated to propel the expansion of the automated analyzers market moving forward. This rise in chronic conditions is attributed to aging populations, unhealthy lifestyles, and increased urbanization globally. Automated analyzers are employed in chronic disease management to provide efficient and accurate diagnostic testing, facilitating early detection, ongoing monitoring, and effective treatment for conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, a report published by Kidney Research UK, a UK-based non-profit organization, indicated that approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Among these, 3.25 million are in the advanced stages of the disease, with an additional 3.9 million in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the growing prevalence of chronic diseases is driving the growth of the automated analyzers market.

Automated Analyzers Market Segment Analysis: What Are The Core Market Categories?

The automated analyzers market covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

Automated Analyzers Market Growth Trends Reshaping The Competitive Landscape

Leading companies in the automated analyzers market are concentrating on developing innovative solutions, such as automated clinical chemistry analyzers, to elevate efficiency, accuracy, and throughput in diagnostic laboratories. These advanced instruments are utilized in labs to perform a wide array of chemical tests on blood and other bodily fluids with minimal human intervention, consequently boosting the effectiveness and precision of diagnostic testing. For example, in January 2024, Beckman Coulter, a US-based manufacturing company, introduced the DxC 500 AU Chemistry Analyzer, representing a state-of-the-art advancement in automated clinical chemistry. Equipped with over 120 high-quality assays, this analyzer is specifically engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to improve testing efficiency and facilitate clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that employ hub-and-spoke models, the DxC 500 AU enhances overall operational efficiency and expands access to essential testing services.

Automated Analyzers Market Competitive Overview And Top Companies

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

View The Full Automated Analyzers Market Report:

https://thebusinessresearchcompany.com/report/automated-analyzers-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Automated Analyzers Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Automated Analyzers Market Between 2026 And 2030?

The automated analyzers market has experienced substantial expansion in recent years. It is projected to increase from $5.39 billion in 2025 to $5.79 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.4%. Historically, this growth was driven by factors such as the reliance on manual and semi-automated testing methods, limited laboratory workforce efficiency, increasing clinical testing volumes, the growth of diagnostic laboratories, and a dependence on conventional analyzers.

The automated analyzers market is anticipated to experience robust expansion over the coming years. This market is projected to reach $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. The projected growth during this period is largely driven by continuous advancements in fully automated analyzers, the incorporation of AI and big data analytics, an increasing need for rapid diagnostic tools, the broadening scope of genomics and proteomics research, and the widespread implementation of point-of-care testing solutions. Key trends expected over the forecast period encompass the greater adoption of automated laboratory systems, a growing requirement for high-throughput sample processing, the integration of multi-functional analyzers within laboratories, significant expansion in clinical diagnostics and research applications, and improvements in the accuracy and standardization of analytical testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

What Influential Factors Are Boosting The Automated Analyzers Market Demand?

The increasing incidence of chronic illnesses is anticipated to drive the expansion of the automated analyzers market in the future. This surge in chronic disease prevalence is attributed to factors such as aging populations, detrimental lifestyle choices, and heightened global urbanization. Automated analyzers play a crucial role in managing chronic diseases by facilitating efficient and precise diagnostic tests, which in turn allows for the early identification, ongoing supervision, and therapeutic intervention for conditions such as diabetes, cardiovascular diseases, and kidney disorders. As an illustration, a report released by Kidney Research UK, a non-profit organization based in the UK, in June 2023 indicated that roughly 7.2 million individuals in the UK suffer from chronic kidney disease, accounting for more than 10% of the populace. Among these individuals, 3.25 million are contending with advanced forms of the illness, while another 3.9 million are in its initial phases. Projections suggest that by 2033, the total count of people impacted by chronic kidney disease will escalate to 7.61 million. Consequently, the expanding occurrence of chronic illnesses is fueling the expansion of the automated analyzers market.

What Segment Categories Are Evaluated In The Automated Analyzers Market Study?

The automated analyzers market covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

What Trends Are Driving Changes In The Automated Analyzers Market?

Companies in the automated analyzers market are concentrating on developing innovative solutions, such as automated clinical chemistry analyzers, to boost efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers are advanced instruments utilized in labs to conduct a broad spectrum of chemical tests on blood and other bodily fluids with minimal human involvement, thereby improving the efficiency and precision of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, representing a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to boost testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.

Who Are The Firms Contributing To The Automated Analyzers Market Ecosystem?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

Access The Complete Automated Analyzers Market Report:

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which Region Holds The Largest Share In The Automated Analyzers Market?

North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Automated Analyzers Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp

Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas And Electrolyte Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Veterinary Hematology Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Automated Analyzers Market Grow Between 2026 And 2030?

The automated analyzers market size has experienced strong growth in recent years. It is projected to increase from $5.39 billion in 2025 to $5.79 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically can be attributed to manual and semi-automated testing methods, limited laboratory workforce efficiency, increasing clinical testing volumes, the growth of diagnostic laboratories, and reliance on conventional analyzers.

The automated analyzers market is projected to experience robust expansion in the coming years. This market is anticipated to reach a valuation of $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the forecast period include enhancements in fully automated analyzers, their integration with AI and big data analytics, an increasing need for rapid diagnostics, the ongoing expansion of genomics and proteomics research, and the wider adoption of point-of-care testing solutions. Key trends defining the forecast period involve the growing implementation of automated laboratory systems, an escalating demand for high-throughput sample processing, the incorporation of multi-functional analyzers within laboratory settings, an expansion in clinical diagnostics and research applications, and improvements in the accuracy and standardization of analytical testing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

Which Factors Are Influencing The Growth Of The Automated Analyzers Market?

The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the automated analyzers market in the coming years. This surge in chronic disease prevalence globally stems from factors like aging populations, unhealthy lifestyles, and increased urbanization. Automated analyzers are integral to chronic disease management, providing efficient and accurate diagnostic testing that enables early detection, monitoring, and treatment of conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, a report published by Kidney Research UK, a UK-based non-profit organization, stated that approximately 7.2 million people in the UK are living with chronic kidney disease, accounting for over 10% of the population. Among these, 3.25 million are in the advanced stages of the disease, with an additional 3.9 million in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Thus, the growing prevalence of chronic diseases is propelling the growth of the automated analyzers market.

What Segment Categories Shape The Automated Analyzers Market Segment Landscape?

The automated analyzers market covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

Which Trends Are Influencing Demand In The Automated Analyzers Market?

Leading companies in the automated analyzers market are concentrating on developing innovative solutions, such as automated clinical chemistry analyzers, to elevate efficiency, accuracy, and processing capacity in diagnostic laboratories. These automated clinical chemistry analyzers are sophisticated instruments utilized in labs to perform a wide array of chemical tests on blood and other bodily fluids with minimal human involvement, thereby enhancing the speed and correctness of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, introduced the DxC 500 AU Chemistry Analyzer, representing a significant advancement in automated clinical chemistry. Equipped with over 120 high-quality assays, this analyzer is engineered to considerably enhance the capabilities of satellite and independent community hospital labs. It integrates advanced automation, streamlined workflows, and standardized reagents to boost testing efficiency and support clinical decision-making. By serving as an essential complement to central hub laboratories within healthcare systems employing hub-and-spoke models, the DxC 500 AU improves overall efficiency and expands access to vital testing services.

Who Are The Companies Operating Across The Automated Analyzers Market Value Chain?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

Get The Full Automated Analyzers Market Report:

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Where Is The Automated Analyzers Market Most Concentrated Geographically?

North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Automated Analyzers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp

Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas And Electrolyte Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Veterinary Hematology Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Automated Analyzers Market During The Forecast Period 2026–2030?

The market size for automated analyzers has experienced robust expansion in recent years. This market is projected to expand from $5.39 billion in 2025 to $5.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this growth was driven by factors such as the prevalence of manual and semi-automated testing methods, constraints in laboratory workforce efficiency, a rise in clinical testing volumes, the proliferation of diagnostic laboratories, and a dependence on conventional analyzers.

The automated analyzers market is anticipated to experience significant expansion over the coming years. This market is projected to reach $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the forecast period include advancements in fully automated analyzers, the integration of AI and big data analytics, increasing demand for rapid diagnostics, the expansion of genomics and proteomics research, and the widespread adoption of point-of-care testing solutions. Key trends expected over the same period encompass the growing adoption of automated laboratory systems, an escalating demand for high-throughput sample processing, the incorporation of multi-functional analyzers in laboratories, expansion in clinical diagnostics and research applications, and improved accuracy and standardization in analytical testing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

Which Major Factors Are Driving The Expansion Of The Automated Analyzers Market?

The increasing incidence of chronic illnesses is anticipated to drive the expansion of the automated analyzers market in the future. This surge in chronic disease cases stems from an aging global populace, detrimental lifestyle choices, and heightened urbanization. Automated analyzers play a crucial role in managing chronic diseases by facilitating precise and effective diagnostic tests, which aids in the prompt identification, continuous observation, and therapeutic intervention for ailments such as diabetes, cardiovascular diseases, and kidney disorders. For example, in June 2023, a report issued by Kidney Research UK, a non-profit organization based in the UK, indicated that around 7.2 million individuals in the UK are affected by chronic kidney disease, accounting for more than 10% of the population. Among these individuals, 3.25 million suffer from advanced forms of the disease, whereas another 3.9 million are in its initial phases. Projections suggest that by 2033, the total number of people afflicted with chronic kidney disease will increase to 7.61 million. Consequently, the growing occurrence of chronic illnesses is fostering expansion within the automated analyzers market.

What Market Segments Are Evaluated Within The Automated Analyzers Market?

The automated analyzers market covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

What Industry Trends Are Redefining The Automated Analyzers Market?

Major companies operating in the automated analyzers market are focusing on developing advanced solutions, including automated clinical chemistry analyzers, to enhance efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers are sophisticated instruments used in laboratories to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, thereby boosting the efficiency and accuracy of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, introduced the DxC 500 AU Chemistry Analyzer, which signifies a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly improve the capabilities of satellite and independent community hospital labs. It incorporates sophisticated automation, streamlined workflows, and standardized reagents to enhance testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.

Who Are The Top Market Participants Influencing The Automated Analyzers Market?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

Read the full automated analyzers market report here:

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which Region Currently Holds The Largest Share Of The Automated Analyzers Market?

North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automated Analyzers Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp

Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas And Electrolyte Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Veterinary Hematology Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the inorganic ceramic membrane market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Automated Analyzers Market be in 2030 compared with 2026?

The automated analyzers market size has shown strong growth in recent years. This market is expected to increase from $5.39 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The historical period’s expansion was driven by elements such as manual and semi-automated testing methods, inefficiencies in the laboratory workforce, rising clinical testing volumes, the proliferation of diagnostic laboratories, and a dependence on conventional analyzers.

The automated analyzers market size is anticipated to undergo significant growth in the upcoming years. It is predicted to expand to $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This projected growth throughout the forecast period is fueled by advancements in fully automated analyzers, their integration with AI and big data analytics, the escalating demand for rapid diagnostics, the broadening of genomics and proteomics research, and the widespread adoption of point-of-care testing solutions. Prominent developments expected during this period include the increasing incorporation of automated laboratory systems, a rising need for high-throughput sample processing, the integration of multi-functional analyzers in laboratory settings, expansion in clinical diagnostics and various research applications, and improvements in the accuracy and standardization of analytical testing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

What Drivers Are Guiding Growth Patterns In The Automated Analyzers Market?

The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the automated analyzers market moving forward. This rise in chronic conditions stems from global factors such as aging populations, unhealthy lifestyles, and intensified urbanization. Automated analyzers are utilized in the management of chronic diseases for efficient and accurate diagnostic testing, which enables early detection, monitoring, and treatment of ailments like diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, as per a report from Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are currently living with chronic kidney disease, which constitutes over 10% of the population. Out of these, 3.25 million are in advanced stages of the illness, while a further 3.9 million are in early stages. By 2033, the figure for individuals affected by chronic kidney disease is predicted to climb to 7.61 million. Therefore, the escalating prevalence of chronic diseases is significantly driving the growth of the automated analyzers market.

How Is The Automated Analyzers Market Divided Into Segments?

The automated analyzers market covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

Which Trends Are Influencing The Development Of The Automated Analyzers Market?

Leading companies in the automated analyzers market are concentrating on developing advanced solutions, such as automated clinical chemistry analyzers, to elevate the efficiency, accuracy, and throughput within diagnostic laboratories. Automated clinical chemistry analyzers are sophisticated instruments utilized in laboratories to conduct a broad spectrum of chemical tests on blood and other bodily fluids with minimal human involvement, thereby enhancing the effectiveness and precision of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing firm, launched the DxC 500 AU Chemistry Analyzer, representing a significant stride in automated clinical chemistry. Featuring over 120 high-quality assays, this analyzer is engineered to considerably improve the capacities of satellite and independent community hospital labs. It integrates advanced automation, streamlined workflows, and standardized reagents to optimize testing efficiency and assist in clinical decision-making. By serving as an essential complement to central hub laboratories within healthcare systems that employ hub-and-spoke models, the DxC 500 AU boosts overall efficiency and expands access to critical testing services.

Which Key Players Are Driving Competition In The Automated Analyzers Market?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which Region Is Projected To Lead The Automated Analyzers Market During The Forecast Period?

North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Automated Analyzers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp

Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company

Hematology Analyzers And Reagents Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas And Electrolyte Analyzers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Veterinary Hematology Analyzers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Discover trends, market shifts, and competitive outlooks for the automated analyzers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Automated Analyzers Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size for automated analyzers has seen a significant increase. It is projected to escalate from $5.02 billion in 2024 to approximately $5.39 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period resulted from the heightened awareness surrounding preventative healthcare, the expanding older population, the increasing desire for non-invasive diagnostic procedures, the widening scope of clinical research, and the growth of drug development operations.

The market size for automated analyzers is projected to experience significant expansion in the coming years, with an expected value of $7.11 billion by 2029, growing at a CAGR of 7.2%. Factors contributing to this growth during the forecast period include the broadening scope of veterinary diagnostics, increased emphasis on minimizing diagnostic inaccuracies, enhanced patient outcomes, telemedicine growth, and remote monitoring. Foreseen trends within this period involve the introduction of innovative biomarkers, point-of-care diagnostics, home-based diagnostic equipment, downsizing of diagnostic devices, and the creation of multi-analyte testing platforms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

What are the Fundamental Drivers and Innovations Shaping the Automated Analyzers Market?

The increasing occurrence of chronic diseases is predicted to fuel the expansion of the automated analyzers market. The spread of chronic diseases is escalating owing to older demographics, unhealthy lifestyles, and global urbanisation. Automated analyzers are utilised in managing chronic diseases as they provide efficient and precise diagnostic tests, facilitating the early identification, monitoring, and treatment of diseases such as diabetes, cardiovascular diseases, and kidney disorders. For example, in June 2023, Kidney Research UK, a non-profit organization based in the UK, reported that approximately 7.2 million people in the UK are suffering from chronic kidney disease, accounting for more than 10% of the population. Out of these, 3.25 million are in the critical stages of the disease, whilst an extra 3.9 million are in the initial stages. The number of individuals afflicted with chronic kidney disease is anticipated to increase to 7.61 million by 2033. Consequently, the upward trend in the occurrence of chronic diseases is stimulating the growth of the automated analyzers market.

How Is the Automated Analyzers Market Segmented?

The automated analyzersmarket covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp

Which Regions Are Driving the Next Phase of the Automated Analyzers Market Growth?

North America was the largest region in the automated analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Automated Analyzers Market?

Firms dominating the automated analyzers market are prioritizing the creation of innovative products such as automated clinical chemistry analyzers that improve performance, precision, and productivity in diagnostic labs. The term automated clinical chemistry analyzers refers to state-of-the-art tools that laboratories use to conduct various chemical tests on blood and other body fluids with limited human interference, thereby boosting effectiveness and accuracy in diagnostics. For example, in January 2024, Beckman Coulter, a manufacturing company based in the US, unveiled the DxC 500 AU Chemistry Analyzer, an innovative leap in the automated clinical chemistry field. Furnished with over 120 top-notch assays, this analyzer is designed to substantially augment the potentialities of satellite and standalone community hospital labs. It couples high-level automation, streamlined workflow, and standardized reagents to escalate testing efficiency and assist in clinical interpretations. The DxC 500 AU operates as an important addition to central hub laboratories in healthcare systems using hub-and-spoke designs, improving overall efficiency and increasing the availability of crucial testing services.

View the full report here:

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

How Is the Automated Analyzers Market Defined and What Are Its Core Parameters?

Automated analyzers are laboratory devices designed to perform repetitive analytical tests with minimal human intervention. They enhance efficiency by processing large volumes of samples accurately and rapidly. These systems are commonly used in clinical, chemical, and hematological analyses.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19322

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the automated analyzers market grown in recent years?

The automated analyzers market has experienced strong expansion, anticipated to rise from $5.02 billion in 2024 to $5.39 billion in 2025, at a CAGR of 7.4%. Growth in prior years was influenced by greater awareness of preventive healthcare, an aging population, rising demand for non-invasive diagnostics, clinical research expansion, and drug development activities.

How is the automated analyzers market size expected to evolve during the forecast period?

The automated analyzers market is projected to experience strong growth, reaching $7.11 billion by 2029, with a CAGR of 7.2%. Factors driving growth include the expansion of veterinary diagnostics, efforts to reduce diagnostic errors, improved patient outcomes, the rise of telemedicine, and increased remote monitoring. Key trends include advancements in novel biomarkers, point-of-care diagnostics, home-based diagnostic tools, miniaturization of devices, and the development of multi-analyte testing platforms.

Get your automated analyzers market report here!

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which key drivers are propelling the automated analyzers market’s growth?

The automated analyzers market is expected to grow due to the rising prevalence of chronic diseases, driven by aging populations, unhealthy lifestyles, and global urbanization. These analyzers support efficient diagnostic testing for conditions like diabetes, cardiovascular diseases, and kidney disorders. For instance, a June 2023 report by Kidney Research UK highlighted that 7.2 million people in the UK have chronic kidney disease, with projections reaching 7.61 million by 2033. This increasing prevalence is fueling market expansion.

What are the market segments in the automated analyzers industry?

The automated analyzersmarket covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

Which leading companies are shaping the growth of the automated analyzers market?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson, and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

What key trends are currently impacting the automated analyzers market’s development?

Major companies in the automated analyzers market are emphasizing the development of innovative solutions like automated clinical chemistry analyzers to improve efficiency, accuracy, and throughput in diagnostic laboratories. These analyzers perform chemical tests on blood and other bodily fluids with minimal human intervention. In January 2024, Beckman Coulter, a US-based manufacturer, introduced the DxC 500 AU Chemistry Analyzer, featuring over 120 high-quality assays. This system enhances the capabilities of satellite and community hospital labs by integrating automation, streamlined workflows, and standardized reagents, improving testing efficiency and supporting clinical decision-making. It serves as a vital complement to central hub laboratories in healthcare systems following the hub-and-spoke model.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19322

Which geographic areas are influencing the growth of the automated analyzers market?

North America was the largest region in the automated analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas and Electrolyte Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Spectrum Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spectrum-analyzers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the automated analyzers market grown in recent years?

The automated analyzers market has experienced strong expansion, anticipated to rise from $5.02 billion in 2024 to $5.39 billion in 2025, at a CAGR of 7.4%. Growth in prior years was influenced by greater awareness of preventive healthcare, an aging population, rising demand for non-invasive diagnostics, clinical research expansion, and drug development activities.

How is the automated analyzers market size expected to evolve during the forecast period?

The automated analyzers market is projected to experience strong growth, reaching $7.11 billion by 2029, with a CAGR of 7.2%. Factors driving growth include the expansion of veterinary diagnostics, efforts to reduce diagnostic errors, improved patient outcomes, the rise of telemedicine, and increased remote monitoring. Key trends include advancements in novel biomarkers, point-of-care diagnostics, home-based diagnostic tools, miniaturization of devices, and the development of multi-analyte testing platforms.

Get your automated analyzers market report here!

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which key drivers are propelling the automated analyzers market’s growth?

The automated analyzers market is expected to grow due to the rising prevalence of chronic diseases, driven by aging populations, unhealthy lifestyles, and global urbanization. These analyzers support efficient diagnostic testing for conditions like diabetes, cardiovascular diseases, and kidney disorders. For instance, a June 2023 report by Kidney Research UK highlighted that 7.2 million people in the UK have chronic kidney disease, with projections reaching 7.61 million by 2033. This increasing prevalence is fueling market expansion.

What are the market segments in the automated analyzers industry?

The automated analyzersmarket covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

Which leading companies are shaping the growth of the automated analyzers market?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson, and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

What key trends are currently impacting the automated analyzers market’s development?

Major companies in the automated analyzers market are emphasizing the development of innovative solutions like automated clinical chemistry analyzers to improve efficiency, accuracy, and throughput in diagnostic laboratories. These analyzers perform chemical tests on blood and other bodily fluids with minimal human intervention. In January 2024, Beckman Coulter, a US-based manufacturer, introduced the DxC 500 AU Chemistry Analyzer, featuring over 120 high-quality assays. This system enhances the capabilities of satellite and community hospital labs by integrating automation, streamlined workflows, and standardized reagents, improving testing efficiency and supporting clinical decision-making. It serves as a vital complement to central hub laboratories in healthcare systems following the hub-and-spoke model.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19322

Which geographic areas are influencing the growth of the automated analyzers market?

North America was the largest region in the automated analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas and Electrolyte Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Spectrum Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spectrum-analyzers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Automated Analyzers Market, and What Are the Key Drivers?

In recent years, the market size for automated analyzers has seen significant growth. The market is projected to expand from $5.02 billion in 2024 to $5.39 billion in 2025, representing a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the historic period include heightened awareness of preventive healthcare, an increase in the elderly population, a surge in demand for non-invasive diagnostic tests, growth in clinical research, and an increase in drug development activities.

The market size of automated analyzers is predicted to experience formidable growth in the coming years. The market is forecasted to reach $7.11 billion in 2029, growing with a compound annual growth rate (CAGR) of 7.2%. This growth during the projected period can be credited to the growth of veterinary diagnostic operations, increasing attention towards reducing diagnostic inaccuracies, enhancing patient results, expansion of telemedicine, and heightening focus on remote monitoring. The period is also anticipated to witness several emerging trends, including all-new biomarkers, point-of-care diagnostics, home-based diagnostic tools, device miniaturization in diagnostics, and the creation of platforms capable of multi-analyte testing.

Which Primary Drivers Are Supporting the Continued Expansion of the Automated Analyzers Market?

The escalating incidence of chronic illnesses is predicted to catalyze the expansion of the automated analyzers market in the near future. Chronic diseases are becoming increasingly common due to factors such as aging populations, detrimental lifestyle habits, and global urbanization. Automated analyzers function in the management of chronic diseases by providing precise and effective diagnostic tests, which aids in the early identification, surveillance, and treatment of ailments such as diabetes, cardiovascular diseases, and renal disorders. For example, a report by Kidney Research UK, a nonprofit organization in the UK, disclosed in June 2023 that approximately 7.2 million individuals, or more than 10% of the population, in the UK are struggling with chronic kidney disease. Out of these, 3.25 million are battling the advanced stages of their disease, while another 3.9 million are in the early stages. By 2033, the count of those affected by chronic kidney disease is expected to climb to 7.61 million. Hence, the surging incidence of chronic diseases is propelling the expansion of the automated analyzers market.

Explore Comprehensive Insights Into The Global Automated Analyzers Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

Which Companies Are Leading the Charge in Expanding the Automated Analyzers Market?

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson, and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc

What New Trends Are Reshaping the Automated Analyzers Market and Its Opportunities?

Leading businesses in the automated analyzers market are concentrating on creating innovative solutions like automated clinical chemistry analyzers to improve proficiency, accuracy, and throughput in diagnostic labs. Automated clinical chemistry analyzers are advanced devices used in labs to conduct a broad range of chemical tests on blood and other body fluids with minimal human involvement, thus augmenting the efficiency and precision of diagnostic testing. For instance, a manufacturing company from the US, Beckman Coulter, introduced DxC 500 AU Chemistry Analyzer in January 2024. This cutting-edge progression in automated clinical chemistry boasts of over 120 high-quality assays and is designed to substantially enhance the capabilities of independent community hospital labs and satellite. It combines refined automation, streamlined workflows, and standardised reagents to elevate testing efficiency and assist clinical decision-making. Serving as a crucial supplement to central hub labs within health systems employing hub-and-spoke models, the DxC 500 AU amplifies overall efficiency and broadens the reach to vital testing services.

Secure Your Global Automated Analyzers Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which Key Segments of the Automated Analyzers Market Are Poised for Growth and Innovation?

The automated analyzersmarket covered in this report is segmented –

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems

2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers

3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers

4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers

What Are the Top Regions Fueling Growth in the Automated Analyzers Market?

North America was the largest region in the automated analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Automated Analyzers Market Defined Across Different Regions?

Automated analyzers are laboratory devices designed to perform repetitive analytical tests with minimal human intervention. They enhance efficiency by processing large volumes of samples accurately and rapidly. These systems are commonly used in clinical, chemical, and hematological analyses.

Browse Through More Similar Reports By The Business Research Company:

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas and Electrolyte Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Spectrum Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spectrum-analyzers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate Can Be Expected in the Automated Analyzers Market from 2024 Through 2033?

The automated analyzers market is projected to expand from $4.68 billion in 2023 to $5.02 billion in 2024, reflecting a CAGR of 7.2%. Growth has been driven by rising awareness of preventive healthcare, an aging population, increasing demand for non-invasive diagnostics, and advancements in clinical research and drug development.

The automated analyzers market is projected to grow significantly, reaching $6.64 billion by 2028 with a CAGR of 7.3%. This growth is driven by advancements in veterinary diagnostics, efforts to reduce diagnostic errors, telemedicine expansion, and developments in home-based and point-of-care diagnostic devices. Key trends include the emergence of multi-analyte platforms, novel biomarkers, and miniaturized diagnostic devices.

Claim Your Free Sample of the Global Automated Analyzers Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp

What Dynamics Are Shaping the Growth of the automated analyzers Market?

The growth of the automated analyzers market is expected to be driven by the increasing prevalence of chronic diseases. Factors like aging populations, unhealthy lifestyles, and urbanization are contributing to the rise in chronic diseases. Automated analyzers are essential for managing these conditions, such as diabetes, cardiovascular diseases, and kidney disorders, by providing accurate and efficient diagnostic testing. For example, Kidney Research UK reported that 7.2 million people in the UK are living with chronic kidney disease, a number projected to increase to 7.61 million by 2033.

What Are the Essential Segments of the Automated Analyzers Market?

1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types

2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types

3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users

What Are the Defining Trends in the Evolving 61 Market?

Companies in the automated analyzers market are focusing on creating innovative solutions, such as automated clinical chemistry analyzers, to improve efficiency, accuracy, and throughput in diagnostic labs. These advanced devices perform a variety of chemical tests on blood and other bodily fluids with minimal human involvement, improving diagnostic accuracy. For example, in January 2024, Beckman Coulter introduced the DxC 500 AU Chemistry Analyzer, designed to enhance the capabilities of community hospital labs. With over 120 high-quality assays, this analyzer integrates automation, standardized reagents, and streamlined workflows to boost testing efficiency and support clinical decisions, improving access to essential testing services in healthcare systems using hub-and-spoke models.

Order Now for Fast Delivery of Your Automated Analyzers Market Report!

https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report

Which Regions Are Emerging as Leaders in the Automated Analyzers Market?

North America was the largest region in the automated analyzers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Automated Analyzers Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the automated analyzers market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Automated Analyzers Market Include

1. Automated Analyzers Market Executive Summary

2. Automated Analyzers Market Segments

3. Automated Analyzers Market Size And Template Market Growth Rate

4. Key Automated Analyzers Market Trends

5. Major Automated Analyzers Market Drivers

……

25. Key Mergers And Acquisitions In The Automated Analyzers Market

26. Top Automated Analyzers Companies

27. Automated Analyzers Market Opportunities And Strategies

28. Automated Analyzers Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Hemostasis Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Blood Gas And Electrolyte Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-gas-and-electrolyte-analyzers-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: